# Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT

Source: https://onco.cc/trials/nct07455903/  
OnCo record `nct07455903` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Leuprolide, Degarelix, Relugolix, Triptorelin, Bicalutamide and Flotufolastat F-18 in Prostate cancer, run by Baptist Health South Florida, now recruiting.

## Summary

Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT is a phase 2 interventional study registered as NCT07455903 by Baptist Health South Florida, with 50 participants planned, started 2026-07-29 and due to reach its primary completion in 2030-02. Interventions recorded: Leuprolide, Degarelix, Relugolix, Triptorelin, Bicalutamide, 18-F Flotufolastat PSMA PET, Radical prostatectomy. Conditions recorded: Prostate Cancer, Localized Prostate Carcinoma.

Linked to the drug Flotufolastat F-18 because the registry names it among its interventions and Prostate cancer among its conditions. Registry record only: no result has been read by an editor.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-22
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07455903
- Phase: 2
- Setting: Assessing the Efficacy of Neoadjuvant Androgen Deprivation Therapy (ADT) Utilizing 18F-Flotufolastat PSMA PET/CT in Patients With High-Risk Localized Prostate Cancer (LHRPC)
- Sponsor: Baptist Health South Florida
- Enrolled: 50

## Sources

- ClinicalTrials.gov NCT07455903: https://clinicaltrials.gov/study/NCT07455903

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/)
- drugs: [Bicalutamide](https://onco.cc/drugs/bicalutamide/), [Degarelix](https://onco.cc/drugs/degarelix/), [Flotufolastat F-18](https://onco.cc/drugs/flotufolastat/), [Leuprolide (leuprorelin) and GnRH agonists](https://onco.cc/drugs/leuprolide/), [Relugolix](https://onco.cc/drugs/relugolix/), [Triptorelin](https://onco.cc/drugs/triptorelin/)

---
JSON: https://onco.cc/api/v1/entities/nct07455903.json